CapsoVision (CV) Cash & Current Investments (2024 - 2025)
CapsoVision's (CV) quarterly Cash & Current Investments came in at $10.1 million in Q4 2025, up 8.51% year-on-year from $9.3 million in Q4 2024, and down 43.15% quarter-over-quarter from $17.8 million in Q3 2025.
CapsoVision (CV) Cash & Current Investments (2024 - 2025) Analysis & Trends
CapsoVision has disclosed Cash & Current Investments across 2 years of filings, most recently posting $10.1 million for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $10.1 million, up 8.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.1 million (up 8.51% YoY), and the FY2025 annual result was $10.1 million, up 8.51% from the prior year.
- Cash & Current Investments came in at $10.1 million for Q4 2025 at CapsoVision, down from $17.8 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $17.8 million in Q3 2025 to a low of $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | CapsoVision | 176.55 Mn | 166.44 Mn | 1.95 Mn | 10.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 17.79 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Dec 31, 2024 | 9.32 Mn |